Trials / Completed
CompletedNCT05409157
A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants
A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of [14C] BMS-986166 in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the drug levels of BMS-986166 in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986166 | Specified dose on specified days |
| DRUG | Bisacodyl | Specified dose on specified days |
Timeline
- Start date
- 2022-06-17
- Primary completion
- 2022-10-15
- Completion
- 2022-10-15
- First posted
- 2022-06-08
- Last updated
- 2023-03-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05409157. Inclusion in this directory is not an endorsement.